Parametre der, under behandling i uge 24, kunne forudsige udvikling af lægemiddelresistent virus efter 104 uger, var HBV DNA > 300 kopier/ ml og øgning af serum ALT.
On-treatment response parameters at week 24 that predicted emergence of drug resistant virus by week 104 were HBV DNA > 300 copies/ ml and elevation of serum ALT.